Koers Peloton Therapeutics, Inc.
Aandelen
PLTX
US70614L1044
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01-11-17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01-01-11 |
David Chang
BRD | Director/Board Member | 64 | 01-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,41% | 105 mld. | |
+3,90% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,44% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,24% | 14,52 mld. | |
+5,76% | 14,09 mld. | |
+27,72% | 10,99 mld. |